Titan Pharmaceuticals (NASDAQ: TTNP)
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Titan Pharmaceuticals (NASDAQ: TTNP) through any online brokerage.
The latest price target for Titan Pharmaceuticals (NASDAQ: TTNP) was reported by Maxim Group on Thursday, May 26, 2022. The analyst firm set a price target for 0.00 expecting TTNP to fall to within 12 months (a possible -100.00% downside). 1 analyst firms have reported ratings in the last year.
The stock price for Titan Pharmaceuticals (NASDAQ: TTNP) is $1.31 last updated August 10, 2022, 8:00 PM UTC.
A quarterly cash dividend of $0.00 per share of Class A Common Stock. The quarterly cash dividend was payable on Invalid DateTime to stockholders of record on December 20, 2001.
Titan Pharmaceuticals’s Q2 earnings are confirmed for Tuesday, August 23, 2022.
There is no upcoming split for Titan Pharmaceuticals.
Titan Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.